Erythrocyte G Protein As A Novel Target For Malarial Chemotherapy

Main Category: Tropical Diseases
Article Date: 02 Jan 2007 - 0:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Kasturi Haldar and colleagues from Northwestern University Medical School, Chicago, investigated a protein in red blood cells (erythrocyte guanine nucleotide regulatory protein Gs) as a novel antimalarial target.

They showed that a commonly used antihypertensive drug, propranolol, decreased Gs activity in red blood cells and inhibited blood-stage malarial parasite growth, as did other drugs of the same class.

When used in combination with existing antimalarials in cell culture, propranolol reduced the dose of existing antimalarial drugs required to treat animal models of malarial infection.

Erythrocyte G may therefore be a novel antimalarial target; in addition, drugs antagonising erythrocyte Gs could be used in combination therapies with existing antimalarial drugs.

"Erythrocyte G protein as a novel target for malarial chemotherapy"
Murphy SC, Harrison T, Hamm HE, Lomasney JW, Mohandas N, et al
(2006) PLoS Med 3(12): e528.
Link to article online

About PLoS Medicine

PLoS Medicine is an open access, freely available international medical journal. It publishes original research that enhances our understanding of human health and disease, together with commentary and analysis of important global health issues. For more information, visit http://www.plosmedicine.org

About the Public Library of Science

The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org